ALVION
Innovation with a Global Presence
At Alvion, we are rethinking pharmaceuticals with a new business model that creates the pharmaceutical company of tomorrow. We strive for a change that is clearly visible in the various pharmaceutical markets, our model, processes and actions.
Alvion Pharmaceuticals is a IP company focused in the development and manufacturing non infringing and difficult to make generic and added value medicines.
Offering licensing opportunitites with most of the leading pharmaceutical companies in Europe, MENA, Australia, South Africa, LATAM, Asia and Canada, Alvion is delivering innovative technologies, products and services to its partners supporting the business continuity across the lifecycle of the products to millions of patients.
Through its portfolio of products, Alvion is offering generic and added value medicines at an affordable cost utilizing its experience in the global pharmaceutical industry by setting new standards for distributing pharmaceuticals. Targeting on first entry opportunities for all markets with, Alvion is utilizing its know how to implement a strategy to successfully deliver its products, penetrating significant market share. Building strong and long-term collaborations with the most established players across the world, Alvion is creating one of the most dynamic and fastest growing pharmaceutical company in Southern Europe.
Alvion’s success is its partners success on successfully launching its products…
Alvion’s business model:
- Licensing its products to pharmaceutical companies
- Co-developing products with manufacturing companies
